Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Gilead Announces Data on Truvada for HIV Prophylaxis
Gilead Announces Data on Truvada for HIV Prophylaxis
Gilead Announces Data on Truvada for HIV Prophylaxis
Submitted by
admin
on July 24, 2018 - 10:10am
Source:
CP Wire
News Tags:
Gilead Sciences
Truvada
HIV
Headline:
Gilead Announces Data on Truvada for HIV Prophylaxis
snippet:
States with highest use of Truvada for PrEP had significant declines in HIV diagnoses
States with the lowest use saw increases in HIV diagnoses
Truvada was approved for HIV prevention by the FDA in 2012
Do Not Allow Advertisers to Use My Personal information
